Hims & Hers Health, Inc.
Mid Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$29.16+$1.77 (+6.46%)
Hims & Hers Health, Inc.
Mid Cap · Healthcare · Drug Manufacturers - Specialty & Generic
$29.16+$1.77 (+6.46%)
Stock analysis
Get the AI take on HIMS
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$13.74
High$70.43
Today $29.16
RSI (14)
57.0Neutral
03070100
Overall score
37/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$23
Current price
$29.16
Median target
$30
Highest
$42
LowHigh
Operating Record
Revenue
Business mix
Dec 31, 2025Online98.5% · $2.3B
Wholesale1.5% · $36.2M
What's working
- Price / sales: You're paying a modest amount for each dollar of revenue coming in.
What to watch
- Debt exceeds cash by $705.2M, increasing balance-sheet pressure, a warning sign.
- Forward P/E: The price already assumes strong earnings growth that still has to show up.
What the market charges
Forward P/E
Needs attention · 308% above avg
68.94x
Price / sales
Strong · Priced modestly against the revenue it brings in
2.55x
Price / FCF
Rich · Priced far above what its cash flow currently supports
79.10x
EV / EBITDA
Rich · Operating earnings don't yet support this price
204.75x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
-10.5%
ROE
Needs attention · Unfavorable
-32.0%
Debt / equity
Needs attention · Unfavorable
4.77x
Current ratio
Weak · Not enough on hand to cover near-term bills
0.93x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $6.57B | - | +28.0% | 37 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |